A few years ago, when west Africa was plagued by an devastating Ebola outbreak, we tried out our protein inhibitors on the Ebola virus. We were delighted when we realized we’d found a group of substances that not only effectively killed the the Ebola virus, but also a range of other viruses as well. Our data shows that the treatment also could also work against the Zika virus, and now we’ve secured funding to take this project forward. We’ve recently hired Dr Åsa Rosenquist, one of the inventors behind an approved treatment for Hepatitis C virus to lead the project. You can read about Åsas’s research in the journal Naturvetarna.
- Medicinal Chemistry Projects available at The Helleday Laboratories Stockholm
- Nicholas Valerie awarded with “Dan Grandér Memorial Prize” for best cancer related PhD thesis at KI
- Sean Rudd receives Grants from VR and Karolinska to start own independent research
- Helleday lab on track to novel potent OGG1 inhibitors beyond TH5487
- Biberach students visit the labs